Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3186 | 1602 | 24.6 | 25% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
158 | 57580 | COMPLEMENT//JOURNAL OF IMMUNOLOGY//COMMON VARIABLE IMMUNODEFICIENCY |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
11278 | 927 | ANTIBODY TO HEPATITIS C VIRUS//ANGIONEUROL//ANTIGEN ANTIBODY DOCKING |
26302 | 212 | CROSS REACTING ANTIGENS//EPIDERMAL ANTIGENS//LEUKOCYTOCLASIS |
27469 | 187 | INTRAVENOUS LASER RADIATION OF BLOOD//INTERNAL DIS 3//ACUTE RADIATION DISEASE |
29175 | 156 | EXPERIMENTAL LEPROSY//COMPLETE PHAGOCYTOSIS//MIDDLE MASS MOLECULES |
34465 | 70 | IGA ALPHA 1 ANTITRYPSIN COMPLEX//IGA ALPHA1 ANTITRYPSIN COMPLEX//LOW MOLECULAR WEIGHT IGM |
35164 | 50 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | EXPERIMENTAL LEPROSY | Author keyword | 3 | 60% | 0% | 3 |
2 | IGA ALPHA 1 ANTITRYPSIN COMPLEX | Author keyword | 1 | 50% | 0% | 2 |
3 | IGA ALPHA1 ANTITRYPSIN COMPLEX | Author keyword | 1 | 100% | 0% | 2 |
4 | LOW MOLECULAR WEIGHT IGM | Author keyword | 1 | 100% | 0% | 2 |
5 | ANTIBODY TO HEPATITIS C VIRUS | Author keyword | 1 | 24% | 0% | 5 |
6 | IGM POLYMERIZATION | Author keyword | 1 | 40% | 0% | 2 |
7 | CROSS REACTING ANTIGENS | Author keyword | 1 | 33% | 0% | 2 |
8 | ANGIONEUROL | Address | 1 | 50% | 0% | 1 |
9 | ANTIGEN ANTIBODY DOCKING | Author keyword | 1 | 50% | 0% | 1 |
10 | AUTOLOGOUS ANTIBODIES | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MONOMERIC IGM | 2 | 67% | 0% | 2 |
2 | EPITHELIAL NEOPLASTIC EFFUSIONS | 1 | 100% | 0% | 2 |
3 | MONOCLONAL RHEUMATOID FACTOR | 1 | 33% | 0% | 2 |
4 | MONOCLONAL RADIOIMMUNOASSAYS | 1 | 50% | 0% | 1 |
5 | MONOMERIC 7S IGM | 1 | 50% | 0% | 1 |
6 | NITRIC OXIDES | 1 | 50% | 0% | 1 |
7 | ANTI COLLAGEN ANTIBODIES | 0 | 33% | 0% | 1 |
8 | CARCINOEMBRYONIC ANTIGEN TEST | 0 | 33% | 0% | 1 |
9 | IGA ALPHA 1 ANTITRYPSIN COMPLEX | 0 | 33% | 0% | 1 |
10 | IMMUNOSORPTION | 0 | 33% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
CIRCULATING IMMUNE-COMPLEXES IN MALIGNANT-MELANOMA | 1988 | 7 | 34 | 79% |
CIRCULATING LOW-MOLECULAR-WEIGHT IGM - A DISEASE MARKER IN AUTOIMMUNE, INFECTIVE, IMMUNODEFICIENT AND B-CELL LYMPHOPROLIFERATIVE DISORDERS | 1992 | 7 | 51 | 39% |
CIRCULATING IMMUNE-COMPLEXES IN HIV-INFECTED PERSONS | 1990 | 11 | 16 | 31% |
CLINICAL-SIGNIFICANCE AND NATURE OF CIRCULATING IMMUNE-COMPLEXES IN MELANOMA PATIENTS | 1985 | 7 | 58 | 72% |
IMMUNE-COMPLEX ASSAYS AND THEIR LIMITATIONS | 1985 | 5 | 13 | 85% |
Measurement of immune complexes is not useful in routine clinical practice | 2000 | 5 | 25 | 28% |
IMMUNE-COMPLEXES IN MAN - DETECTION AND CLINICAL-SIGNIFICANCE | 1985 | 25 | 71 | 21% |
Preeclampsia: The death of Goliath | 2006 | 19 | 112 | 13% |
INCREASED IGM-CONTAINING CIRCULATING IMMUNE-COMPLEXES IN PATIENTS CO-INFECTED WITH HEPATITIS-C AND HEPATITIS-B | 1995 | 6 | 64 | 25% |
HEMOSORPTION IN THE TREATMENT OF BRONCHIAL-ASTHMA | 1989 | 0 | 3 | 100% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANGIONEUROL | 1 | 50% | 0.1% | 1 |
2 | SECTOR IMMUNOANAL INFORMAT | 1 | 29% | 0.1% | 2 |
3 | DNEPROPETROVSK MED | 0 | 33% | 0.1% | 1 |
4 | INTERNAL DIS 3 | 0 | 33% | 0.1% | 1 |
5 | ECOL IMMUNOL | 0 | 18% | 0.1% | 2 |
6 | GEZHOUBA CENT HOSP | 0 | 25% | 0.1% | 1 |
7 | SWIM ACROSS AMER TUMOR IMMUNOL | 0 | 20% | 0.1% | 1 |
8 | INTERFERONS | 0 | 14% | 0.1% | 1 |
9 | URGENT MED | 0 | 11% | 0.1% | 1 |
10 | AVT ADV | 0 | 100% | 0.1% | 1 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000019424 | LDL APHERESIS//LOW DENSITY LIPOPROTEIN APHERESIS//APHERESIS |
2 | 0.0000019067 | EOSINOPHIL CHEMOTACTIC FACTOR//LEUKOREGULIN//RYBINSK RESERVOIR |
3 | 0.0000014482 | P15E//IMMUNE SUPPRESSOR CELLS//IRX 2 |
4 | 0.0000013608 | VESTNIK DERMATOLOGII I VENEROLOGII//BRCN ACTIVATED SEPHAROSE//CURANTIL |
5 | 0.0000011642 | COMPLEMENT//MANNOSE BINDING LECTIN//PAROXYSMAL NOCTURNAL HEMOGLOBINURIA |
6 | 0.0000008714 | CONGENITAL HEART BLOCK//NEONATAL LUPUS//NEONATAL LUPUS ERYTHEMATOSUS |
7 | 0.0000007780 | APPARENT EQUILIBRIUM CONSTANTS//TRANSFORMED THERMODYNAMIC PROPERTIES//TRANSFORMED GIBBS ENERGY |
8 | 0.0000007302 | CA 125//CYFRA 21 1//HE4 |
9 | 0.0000006617 | L FORMS//OPTICAL BEAM CONDENSER//ABSORPTION DATA |
10 | 0.0000006378 | FCRN//NEONATAL FC RECEPTOR//FC GAMMA RECEPTORS |